OpenAI chief executive Sam Altman and his husband Oliver Mulherin have backed a controversial startup investing in genetically engineering babies to eliminate hereditary diseases.
The company, called Preventive, has raised $30 million and established its headquarters in San Francisco to address “devastating genetic conditions.”